此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion

2026年6月16日 更新者:Xiaozhong Wen、State University of New York at Buffalo
The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into either the breastfeeding intervention or the attention placebo control group. The outcomes are postpartum smoking relapse, breastfeeding practices, and maternal and child health.

研究概览

详细说明

We propose a randomized controlled trial to reduce postpartum smoking relapse by breastfeeding promotion from late pregnancy to 12 months postpartum. We will enroll 280 pregnant mothers who successfully quit smoking during this pregnancy (≤28 weeks). After the pre-test, participants who are still smoking abstinent will be randomized into either the breastfeeding intervention group (N=140) or the attention control group (N=140). The intervention group will receive a multicomponent intervention consisting of breastfeeding education, lactation counseling, social support, contingent financial incentives, and early limited formula milk via syringe feeding (optional for at-risk infants). The control group will receive counseling and support focusing on general infant care, with attention and monetary earnings similar to the intervention group. Both groups will receive usual care (i.e., information, education, and Quitline) for postpartum smoking relapse. The outcomes are postpartum smoking relapse, breastfeeding practices, and maternal and child health.

Aim 1 is to examine the efficacy of breastfeeding promotion intervention on postpartum smoking relapse. Aim 2 is to examine potential mediating mechanisms: reductions in stress and negative affect, enhancing mother-infant bonding and maternal sensitivity, and maternal weight retention. Aim 3 is to assess the effects of breastfeeding promotion intervention on maternal and infant health among ex-smoking mothers. This innovative study can yield promising data to support a new intervention to prevent postpartum smoking relapse. It has the potential to reduce smoking-related harms to both the mother and the infant, maximize the protective effects of breastfeeding on infant health and development, and narrow health disparities.

研究类型

介入性

注册 (估计的)

280

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • New York
      • Buffalo、New York、美国、14214
        • 招聘中
        • Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

  • Be pregnant
  • Be 18 years or older
  • Have quit smoking cigarettes during this pregnancy
  • Be willing to receive infant care and breastfeeding education
  • Be able to read, listen, and talk in English

Exclusion Criteria:

  • Medical conditions contraindicating breastfeeding, such as HIV infection, active tuberculosis, and breast removal
  • Current heavy drinking (≥4 standard drinks on any day or ≥8 standard drinks per week)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
安慰剂比较:注意安慰剂对照组
一般婴儿护理咨询和支持
The control group will receive instructions on general pregnancy and infant care from this project
实验性的:Breastfeeding intervention grou
A multicomponent behavioral intervention to promote breastfeeding
The intervention group will receive a multicomponent intervention promoting breastfeeding, including education, lactation counseling, social support, breastfeeding-contingent financial incentives, and early limited formula milk via syringe feeding (optional for at-risk infants).

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Number of participants reporting to smoke
大体时间:12 months postpartum
12 months postpartum

次要结果测量

结果测量
大体时间
Number of participants reporting to breastfeed
大体时间:12months postpartum
12months postpartum
Systolic blood pressure level
大体时间:12 months postpartum
12 months postpartum
Diastolic blood pressure level
大体时间:12 months postpartum
12 months postpartum
Infant weight-for-length z-score
大体时间:12 months of age
12 months of age
Infant length-for-age z-score
大体时间:12 months of age
12 months of age
Infant head circumference
大体时间:12 months of age
12 months of age
Infant arm circumference
大体时间:12 months of age
12 months of age
Number of infants with bronchiolitis
大体时间:12 months of age
12 months of age

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Xiaozhong Wen、State University of New York at Buffalo

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年1月1日

初级完成 (估计的)

2030年7月31日

研究完成 (估计的)

2031年7月31日

研究注册日期

首次提交

2026年6月16日

首先提交符合 QC 标准的

2026年6月16日

首次发布 (实际的)

2026年6月22日

研究记录更新

最后更新发布 (实际的)

2026年6月22日

上次提交的符合 QC 标准的更新

2026年6月16日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • STUDY00002632
  • R01HD117113 (美国 NIH 拨款/合同)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅